Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis

Purpose: Cancer is a leading cause of morbidity and mortality worldwide. Off-label (OL) use of antineoplastic drugs to treat malignancies is prevalent. In this study, we quantified and characterized OL use of antineoplastic drugs to treat malignancies in China. Methods: This was a retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Guoxu, Wu, Min, Zhu, He, Han, Sheng, Chen, Jing, Zhai, Chenchen, Shi, Luwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060556/
https://www.ncbi.nlm.nih.gov/pubmed/33897416
http://dx.doi.org/10.3389/fphar.2021.616453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060556/
https://www.ncbi.nlm.nih.gov/pubmed/33897416
http://dx.doi.org/10.3389/fphar.2021.616453

Ejemplares similares